TERT and colorectal cancer: Akincilar et al. reported that the introduction of TERT promoter mutations at −146C (−146C > T) in colorectal cancer HCT116 cells with the wild-type TERT promoter by CRISPR/Cas9 alters the chromatin status of the TERT promoter to an active conformation.